- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 263/40 - Un atome d'oxygène lié en position 4
Détention brevets de la classe C07D 263/40
Brevets de cette classe: 26
Historique des publications depuis 10 ans
|
1
|
1
|
5
|
2
|
0
|
2
|
3
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| North Carolina State University | 1537 |
8 |
| AstraZeneca AB | 2966 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2088 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 580 |
2 |
| F. Hoffmann-La Roche AG | 7970 |
1 |
| Hoffmann-La Roche Inc. | 3307 |
1 |
| Board of Regents, The University of Texas System | 5667 |
1 |
| Takeda Pharmaceutical Company Limited | 2940 |
1 |
| The Board of Regents for Oklahoma State University | 155 |
1 |
| Dompé Farmaceutici S.p.A. | 261 |
1 |
| Dompe S.p.A. | 13 |
1 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 811 |
1 |
| Vanderbilt University | 1824 |
1 |
| The Board of Regents of the University of Texas System | 2145 |
1 |
| The National Center for Drug Screening | 4 |
1 |
| Suzhou Elite New Pharmaceutical Research and Development Co., Ltd. | 1 |
1 |
| Autres propriétaires | 0 |